Cytosorbents (CTSO) Other financing activities (2010 - 2025)
Cytosorbents (CTSO) posted Other financing activities of $1.4 million for Q1 2025, up 2602.96% on a QoQ basis from $53238.0 in Q1 2024, and up 2602.96% year-over-year from $53238.0 in Q1 2024.
Cytosorbents (CTSO) Other financing activities (2010 - 2025) Analysis & Trends
Cytosorbents' Other financing activities history runs 15 years deep, the most recent figure standing at $1.4 million for Q1 2025.
- Quarterly Other financing activities rose 2602.96% year-over-year to $1.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, changed N/A from the prior year.
- Other financing activities was $1.4 million for Q1 2025 at Cytosorbents, up from $53238.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.4 million in Q1 2025 and bottomed at $4971.0 in Q4 2023.
- A 4-year average of $251571.5 and a median of $64895.5 in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2021 — Other financing activities tumbled 96.0% — and 2025, when it jumped 2602.96%.
- Cytosorbents' Other financing activities stood at $9076.0 in 2021, then tumbled by 45.23% to $4971.0 in 2023, then jumped by 970.97% to $53238.0 in 2024, then soared by 2602.96% to $1.4 million in 2025.
- Business Quant data shows CTSO's Other financing activities at $1.4 million in Q1 2025, $53238.0 in Q1 2024, and $4971.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2024 | 53,238.00 |
| Mar 31, 2024 | 53,238.00 |
| Dec 31, 2023 | 4,971.00 |
| Dec 31, 2023 | 4,971.00 |
| Sep 30, 2023 | 15,928.00 |
| Sep 30, 2023 | 15,928.00 |
| Jun 30, 2023 | 154,829.00 |
| Jun 30, 2023 | 154,829.00 |
| Mar 31, 2023 | 42,550.00 |
| Mar 31, 2023 | 42,550.00 |
| Dec 31, 2021 | 9,076.00 |
| Dec 31, 2021 | 9,076.00 |
| Sep 30, 2021 | 589,718.00 |
| Sep 30, 2021 | 589,718.00 |
| Jun 30, 2021 | 129,852.00 |
| Jun 30, 2021 | 129,852.00 |
| Mar 31, 2021 | 76,553.00 |
| Mar 31, 2021 | 76,553.00 |